Investing Profile

John Yianni

InvestorVC
Partner at Earlybird Venture Capital
Photo of John Yianni, Partner at Earlybird Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
cb
$100K - $5.0M
$1.5M
3
€350m
CompanyStageDateRound SizeTotal Raised
Axon Therapies
Series ASep 2025$32M
$32M
Prothea Technologies
Series AApr 2024$13M
$13M
Perfuze
SeedJan 2019$3M
$53M
Co-investors: Anne Portwich (EQT Group), Daniel O'Mahony (Seroba Life Sciences)
Postdoc Financial Services, Financial Technology, and Business ServicesPresent
VP Technology & Business Development Financial Services, Financial Technology, and Business ServicesPresent
Non-executive director Financial Services, Financial Technology, and Business ServicesPresent
Chairman & CEO Financial Services, Financial Technology, and Business ServicesPresent
Founder and Board Member Financial Services, Financial Technology, and Business ServicesPresent
CEO CryoTherapeutics SAPresent
CEO CryoTherapeutics, Partner Earlybird Venture Capital Financial Services, Financial Technology, and Business ServicesPresent
Partner Earlybird Venture CapitalPresent
The University of Salford PhD Biophysics
Sign in with Google →
Sign in with Google →